TCPC:NASDAQBlackRock TCP Capital Corp. Analysis
Data as of 2026-09-01 - not real-time
$4.16
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $4.16, BlackRock TCP Capital Corp. shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 25.7%. Momentum indicators put RSI at 66.3 (approaching overbought) with MACD reading bearish. The recent range runs from support at $3.25 up to resistance at $4.25.
Valuation screens as undervalued: a P/E of 10.0 sits below the sector average of 16.9. The average analyst target implies 4.2% above today's level. Revenue is contracting at 22.2% on a -61.3% profit margin. The 18.45% dividend yield looks stretched against payout coverage.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 48.0%, a beta of 0.89 and a maximum drawdown of 56.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Valuation screens as undervalued: a P/E of 10.0 sits below the sector average of 16.9. The average analyst target implies 4.2% above today's level. Revenue is contracting at 22.2% on a -61.3% profit margin. The 18.45% dividend yield looks stretched against payout coverage.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 48.0%, a beta of 0.89 and a maximum drawdown of 56.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.
Top Market Events
BlackRock TCP TCPC has been upgraded to a Zacks Rank 2 Buy , reflecting growing optimism about the company's earnings...SANTA MONICA, Calif., August 06, 2026--BlackRock TCP Capital Corp. "we," "us," "our," "TCPC" or the "Company" , a...SANTA MONICA, Calif., July 09, 2026--BlackRock TCP Capital Corp. NASDAQ: TCPC announced today that it will report its...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 4.38
- MACD momentum is negative
- 30-day price change of +25.7%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 10.0 versus sector average of 16.9
- Dividend yield of 18.45% looks stretched against payout coverage
- Trading below the 200-day average of 4.38
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 10.0 versus sector average of 16.9
- Dividend yield of 18.45% looks stretched against payout coverage
- Negative profit margin of -61.3%
Key Metrics & Analysis
Financial Health
Revenue Growth-22.20%
Profit Margin-61.27%
P/E Ratio10.0
ROE-16.79%
ROA5.48%
Debt/Equity164.96
P/B Ratio0.6
Op. Cash Flow$399.7M
Free Cash Flow$58.6M
Industry P/E16.9
Technical Analysis
TrendNeutral
RSI66.3
Support$3.25
Resistance$4.25
MA 20$3.98
MA 50$3.54
MA 200$4.38
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79
Valuation
Target Price$4.33
Upside/Downside4.17%
GradeUndervalued
TypeValue
Dividend Yield18.45%
Risk Assessment
Beta0.89
Volatility48.00%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.